Progeny 3, Inc. holds a focused book of 32 stocks worth $1.9B as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). This quarter they opened Amazon.com Inc and trimmed Alliance Resource Partners. Their largest long position is Cameco Corp at 14% of the equity book. Cloning the disclosed picks since 2013 would be +194% (+8.9%/yr). That is a simulation of the disclosed long book, not audited returns.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1536006/holdings"
Use Arkolith to show Progeny 3, Inc.'s latest holdings, largest changes, and filing provenance.
The reported book (valued from quarter-end) returned +209.3%, a 15.0-point gap that is the cost of the ~45-day 13F disclosure lag a real follower can't avoid.
Growth of $10,000 cloning Progeny 3, Inc.'s disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~45 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: focused book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
86% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Progeny 3, Inc.
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| MORGAN STANLEY | 40 / 32 | $89.6B |
| JPMORGAN CHASE & CO | 40 / 32 | $79.0B |
| GOLDMAN SACHS GROUP INC | 40 / 32 | $42.3B |
| ROYAL BANK OF CANADA | 40 / 32 | $35.1B |
| UBS Group AG | 40 / 32 | $19.6B |
| US BANCORP \DE\ | 40 / 32 | $6.0B |
| OSAIC HOLDINGS, INC. | 40 / 32 | $3.4B |
| BANK OF AMERICA CORP /DE/ | 39 / 32 | $57.6B |
Ranked by how many of Progeny 3, Inc.'s top 32 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Cameco Corp COM | $254.9M | 2.35M | 13.6% | —Held | |
| 2 | Interactive Brokers Group In COM CL A | $147.3M | 2.20M | 7.9% | ▲+3.1% Added · +66K sh | |
| 3 | Api Group Corp COM STK | $143.5M | 3.54M | 7.7% | —Held | |
| 4 | Tic Solutions Inc COM | $100.8M | 15.32M | 5.4% | ▲+0.6% Added · +92K sh | |
| 5 | Ishares TR CORE S&P500 ETF | $90.8M | 139.1K | 4.9% | —Held | |
| 6 | Alliance Resource Partners L UT LTD PART | $89.3M | 3.23M | 4.8% | ▼−1.6% Reduced · −53K sh | |
| 7 | SS&C Technologies Hldgs Inc COM | $85.1M | 1.26M | 4.5% | ▲+12% Added · +133K sh | |
| 8 | GFL Environmental Inc SUB VTG SHS | $80.8M | 1.94M | 4.3% | ▼−5.1% Reduced · −105K sh | |
| 9 | Martin Marietta Matls Inc COM | $66.6M | 113.2K | 3.6% | —Held | |
| 10 | Eqt Corp COM | $64.2M | 1.01M | 3.4% | ▲+3.9% Added · +38K sh | |
| 11 | Enterprise Prods Partners L COM | $63.7M | 1.68M | 3.4% | ▼−3.6% Reduced · −64K sh | |
| 12 | Vanguard Index FDS S&P 500 ETF SHS | $61.7M | 103.3K | 3.3% | —Held | |
| 13 | MPLX LP COM UNIT REP LTD | $58.0M | 1.02M | 3.1% | ▼−4.0% Reduced · −43K sh | |
| 14 | Agnico Eagle Mines Ltd COM | $57.8M | 284.9K | 3.1% | —Held | |
| 15 | Solstice Advanced Matls Inc COM SHS | $55.7M | 731.1K | 3.0% | —Held | |
| 16 | Daktronics Inc COM | $53.7M | 2.75M | 2.9% | —Held | |
| 17 | Energy Transfer LP COM UT LTD PTN | $53.0M | 2.74M | 2.8% | ▼−4.6% Reduced · −132K sh | |
| 18 | Amazon Com Inc COM | $52.1M | 250.1K | 2.8% | ▲New New position | |
| 19 | Sixth Street Specialty Lendn COM | $45.5M | 2.48M | 2.4% | —Held | |
| 20 | Pricesmart Inc COM | $41.0M | 272.1K | 2.2% | ▲+19% Added · +43K sh | |
| 21 | Ares Capital Corp COM | $40.1M | 2.22M | 2.1% | —Held | |
| 22 | Natural Resource Partners L COM UNIT LTD PAR | $37.8M | 312.5K | 2.0% | —Held | |
| 23 | Par Technology Corp COM | $28.9M | 2.17M | 1.5% | ▲+5.6% Added · +115K sh | |
| 24 | Pool Corp COM | $28.3M | 140.0K | 1.5% | ▲New New position | |
| 25 | Berkshire Hathaway Inc Del CL B NEW | $25.5M | 53.2K | 1.4% | —Held | |
| 26 | Blackstone Secd Lending FD COMMON STOCK | $18.3M | 772.2K | 1.0% | —Held | |
| 27 | Cellebrite Di Ltd ORDINARY SHARES | $15.5M | 1.13M | 0.8% | ▲New New position | |
| 28 | Warrior Met Coal Inc COM | $5.1M | 54.2K | 0.3% | —Held | |
| 29 | Abivax Sa SPONSORED ADS | $1.4M | 12.2K | 0.1% | —Held | |
| 30 | Vaxcyte Inc COM | $1.4M | 23.3K | 0.1% | —Held | |
| 31 | Ascendis Pharma A/s SPONSORED ADR | $1.2M | 5.2K | 0.1% | —Held | |
| 32 | Crinetics Pharmaceuticals In COM | $872K | 24.0K | 0.0% | —Held |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 15, 2026 | 32 | $1.9B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 17, 2026 | 37 | $1.9B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 | 34 | $1.9B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 | 30 | $1.8B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 | 30 | $1.5B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 14, 2025 | 32 | $1.3B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 | 34 | $1.2B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 16, 2024 | 29 | $1.0B | 13F-HR/A |
| Q1 2024 | Mar 31, 2024 | May 15, 2024 | 26 | $908.8M | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 14, 2024 | 23 | $806.4M | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 | 21 | $733.2M | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 | 23 | $660.2M | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 | 23 | $589.9M | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 14, 2023 | 22 | $575.9M | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 | 26 | $598.8M | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 | 23 | $496.3M | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 16, 2022 | 23 | $532.7M | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 14, 2022 | 23 | $369.8M | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 16, 2021 | 30 | $401.6M | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 16, 2021 | 26 | $287.5M | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 17, 2021 | 31 | $254.2M | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 16, 2021 | 25 | $189.2M | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Nov 16, 2020 | 24 | $153.9M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.